Chemopreventive and hepatoprotective effects of genistein via inhibition of oxidative stress and the versican/PDGF/PKC signaling pathway in experimentally induced hepatocellular carcinoma in rats by thioacetamide

References

• Foglia B, Parola M. Of FACT complex and oxidative stress response: a KEAP1/NRF2-dependent novel mechanism sustaining hepatocellular carcinoma progression. Gut. 2020;69(2):195–196.
   PubMed Web of Science ®Google Scholar
• McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2020;73(Suppl. 1):4–13.
   PubMedGoogle Scholar
• El-Far YM, Khodir AE, Noor AO, et al. Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis in vivo and in vitro. Redox Rep. 2020;25(1):17–25.
   PubMed Web of Science ®Google Scholar
• El-Far YM, Khodir AE, Emarah ZA, et al. Fucoidan ameliorates hepatocellular carcinoma induced in rats: effect on miR143 and inflammation. Nutr Cancer. 2020;28:1–13.
   Google Scholar
• Flynn MJ, Sayed AA, Sharma R, et al. Challenges and opportunities in the clinical development of immune checkpoint inhibitors for hepatocellular carcinoma. Hepatology. 2019;69(5):2258–2270.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Tateishi R, Koike K. Proteoglycans are attractive biomarkers and therapeutic targets in hepatocellular carcinoma. Int J Mol Sci. 2018;19(10):3070.
   PubMed Web of Science ®Google Scholar
• Goekjian PG, Jirousek MR. Protein kinase C inhibitors as novel anticancer drugs. Expert Opin Investig Drugs. 2001;10(12):2117–2140.
   PubMed Web of Science ®Google Scholar
• Schmitz KJ, Wohlschlaeger J, Lang H, et al. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol. 2008;48(1):83–90. doi:10.1016/j.jhep.2007.08.018.
   PubMed Web of Science ®Google Scholar
• Kim ST, Hong JY, Park SH, et al. First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients. Ther Adv Med Oncol. 2020;12:1758835920926796. doi:10.1177/1758835920926796.
   Web of Science ®Google Scholar
• Wu XP, Yang YP, She RX, et al. microRNA-329 reduces bone cancer pain through the LPAR1-dependent LPAR1/ERK signal transduction pathway in mice. Ther Adv Med Oncol. 2019;11:1758835919875319.
   Web of Science ®Google Scholar
• Tuli HS, Tuorkey MJ, Thakral F, et al. Molecular mechanisms of action of genistein in cancer: recent advances. Front Pharmacol. 2019;10:1336. doi:10.3389/fphar.2019.01336.
   PubMed Web of Science ®Google Scholar
• Lecomte S, Demay F, Ferriere F, et al. Phytochemicals targeting estrogen receptors: beneficial rather than adverse effects? Int J Mol Sci. 2017;18(7):1381.
   Web of Science ®Google Scholar
• Shin SB, Woo SU, Yim H. Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer. Ther Adv Med Oncol. 2019;11:1758835919846375.
   Web of Science ®Google Scholar
• Donovan SM, Andres A, Mathai RA, et al. Soy formula and isoflavones and the developing intestine. Nutr Rev. 2009;67(Suppl 2):S192–S200.
   PubMedGoogle Scholar
• Debbabi H, Bonnin P, Ducluzeau PH, et al. Noninvasive assessment of endothelial function in the skin microcirculation. Am J Hypertens. 2010;23(5):541–546.
   PubMed Web of Science ®Google Scholar
• Huang DQ, Muthiah MD, Zhou L, et al. Predicting HCC response to multikinase inhibitors with in vivo cirrhotic mouse model for personalized therapy. Cell Mol Gastroenterol Hepatol. 2021;11(5):1313–1325. doi:10.1016/j.jcmgh.2020.12.009.
   PubMed Web of Science ®Google Scholar
• Hassan HM, Al-Wahaibi LH, Shehatou GS, et al. Adamantane-linked isothiourea derivatives suppress the growth of experimental hepatocellular carcinoma via inhibition of TLR4-MyD88-NF-κB signaling. Am J Cancer Res. 2021;11(2):350–369.
   PubMed Web of Science ®Google Scholar
• Min WK, Sung HY, Choi YS. Suppression of colonic aberrant crypt foci by soy isoflavones is dose-independent in dimethylhydrazine-treated rats. J Med Food. 2010;13(3):495–502. doi:10.1089/jmf.2009.1208.
   PubMed Web of Science ®Google Scholar
• Rajan RK, Balaji B. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism. Pharm Biol. 2017;55(1):242–251. doi:10.1080/13880209.2016.1258425.
   PubMed Web of Science ®Google Scholar
• Hassan HM, El-Kannishy SMH, Alattar A, et al. Therapeutic effects of blocking β-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion. Biomed Pharmacother. 2021;135:111216.
   PubMed Web of Science ®Google Scholar
• Al-Gayyar MMH, Bagalagel A, Noor AO, et al. The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB. Biomed Pharmacother. 2019;112:108653.
   PubMed Web of Science ®Google Scholar
• Balogh J, Victor D, Asham EH, et al. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;3:41–53.
   PubMed Web of Science ®Google Scholar
• Zhou C, Peng Y, Zhou K, et al. Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2019;8(1):19–28.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Toffanin S, Friedman SL, et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma: a review. Gastroenterology. 2013;144:512–527.
   PubMed Web of Science ®Google Scholar
• Theocharis AD, Skandalis SS, Tzanakakis GN, et al. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J. 2010;277(19):3904–3923.
   PubMed Web of Science ®Google Scholar
• Chodon D, Ramamurty N, Sakthisekaran D. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line. Toxicol In Vitro. 2007;21(5):887–891.
   PubMed Web of Science ®Google Scholar
• Lee SR, Kwon SW, Lee YH, et al. Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation. BMC Cancer. 2019;19(1):6. doi:10.1186/s12885-018-5222-8.
   PubMedGoogle Scholar
• Gavalas NG, Liontos M, Trachana S-P, et al. Angiogenesis-Related pathways in the pathogenesis of ovarian cancer. Int J Mol Sci. 2013;14(8):15885–15909. doi:10.3390/ijms140815885.
   PubMed Web of Science ®Google Scholar
• Heldin C-H. Targeting the PDGF signaling pathway in tumor treatment: a review. Cell Commun Signal. 2013;11:97.
   PubMed Web of Science ®Google Scholar
• Maass T, Thieringer FR, Mann A, et al. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis. Int J Cancer. 2011;128(6):1259–1268.
   PubMed Web of Science ®Google Scholar
• Schönherr E, Kinsella MG, Wight TN. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells. Arch Biochem Biophys. 1997;339(2):353–361. doi:10.1006/abbi.1996.9854.
   PubMed Web of Science ®Google Scholar
• Tuli HS, Tuorkey MJ, Thakral F, et al. Molecular mechanisms of action of genistein in cancer: recent advances: a review. Front Pharmacol. 2019;10:1336.
   PubMed Web of Science ®Google Scholar
• Nikitovic D, Zafiropoulos A, Katonis P, et al. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells. IUBMB Life. 2006;58(1):47–53. doi:10.1080/15216540500531713.
   PubMed Web of Science ®Google Scholar
• Suwiwat S, Ricciardelli C, Tammi R, et al. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res. 2004;10(7):2491–2498.
   PubMed Web of Science ®Google Scholar
• Zhangyuan G, Wang F, Zhang H, et al. Versicanv1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway. Oncogene. 2020;39(6):1213–1230. doi:10.1038/s41388-019-1052-7.
   PubMed Web of Science ®Google Scholar
• Tao L, Huang G, Song H, et al. Cancer associated fibroblasts: an essential role in the tumor microenvironment. Oncol Lett. 2017;14(3):2611–2620.
   PubMed Web of Science ®Google Scholar
• Maass T, Thieringer FR, Mann A, et al. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis. Int J Cancer. 2011;128(6):1259–1268. doi:10.1002/ijc.25469.
   PubMed Web of Science ®Google Scholar
• Li G-DZ, Shi Z, Qi L-L, et al. The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol Lett. 2016;12(5):3045–3050.
   PubMed Web of Science ®Google Scholar
• Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer: a review. Oncogene. 2007;26(22):3291–3310.
   PubMed Web of Science ®Google Scholar
• Cooke M, Magimaidas A, Casado-Medrano V, et al. Protein kinase C in cancer: the top five unanswered questions: a review. Mol Carcinog. 2017;56(6):1531–1542.
   PubMed Web of Science ®Google Scholar
• Kang J-H. Protein kinase C (PKC) isozymes and cancer: a review. New J Sci. 2014. doi:10.1155/2014/231418.
   Google Scholar
• Osman N, Getachew R, Thach L, et al. Platelet-derived growth factor-stimulated versican synthesis but not glycosaminoglycan elongation in vascular smooth muscle is mediated via Akt phosphorylation. Cell Signal. 2014;26(5):912–916. doi:10.1016/j.cellsig.2014.01.019.
   PubMed Web of Science ®Google Scholar
• Cardoso LEM, Little PJ, Ballinger ML, et al. Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways. J Biol Chem. 2010;285(10):6987–6995. doi:10.1074/jbc.M109.088674.
   PubMed Web of Science ®Google Scholar
• Takaki A, Yamamoto K. Control of oxidative stress in hepatocellular carcinoma: helpful or harmful? World J Hepatol. 2015;7(7):968–979.
   PubMedGoogle Scholar
• Park CE, Yun H, Lee EB, et al. The antioxidant effects of genistein are associated with AMP-activated protein kinase activation and PTEN induction in prostate cancer cells. J Med Food. 2010;13(4):815–820. doi:10.1089/jmf.2009.1359.
   PubMed Web of Science ®Google Scholar
• Xin X, Chen C, Hu YY, et al. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD). Biomed Pharmacother. 2019;117:109047.
   PubMed Web of Science ®Google Scholar